<DOC>
	<DOCNO>NCT01247545</DOCNO>
	<brief_summary>Coronary heart disease ( CHD ) lead cause death UK , account 124,000 death ( 2006 ) cost UK economy £7.9 billion year . Patients severe CHD usually treat coronary artery bypass graft ( CABG ) surgery , risk increase due old sicker patient operate . New treatment strategy therefore require improve health outcome high-risk patient undergo CABG without valve ( CABG±valve ) surgery . The hypothesis test research proposal remote ischaemic preconditioning ( RIC ) , virtually cost-free , non-pharmacological simple non-invasive strategy reduce damage heart muscle time surgery , improve health outcome high-risk patient undergo CABG±valve surgery . In research project , 1610 high-risk patient undergo CABG±valve surgery recruit via 28 UK hospital perform heart surgery . Patients randomly allocate receive either RIC control . For RIC , blood pressure cuff place upper arm temporarily deprive oxygen nutrient , intervention show investigator pilot study reduce damage heart muscle 40 % CABG±valve surgery . The investigator determine whether RIC improve health outcome term well patient survival , less heart attack stroke , short hospital stay ; le damage heart , kidney brain surgery ; good heart function post-surgery less chance develop heart failure ; well exercise tolerance quality life .</brief_summary>
	<brief_title>Effect Remote Ischaemic Preconditioning Clinical Outcomes CABG Surgery</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>1 . Patients undergo CABG without valve surgery use blood cardioplegia 2 . Patients age 18 year 3 . Patients additive Euroscore great equal 5 1 . Cardiogenic shock 2 . Cardiac arrest current admission 3 . Pregnancy 4 . Significant peripheral arterial disease affect upper limb 5 . Patients significant hepatic dysfunction ( Prothrombin &gt; 2.0 ratio ) 6 . Patients significant pulmonary disease ( FEV1 &lt; 40 % predict ) 7 . Patients know renal failure GFR &lt; 30 mL/min/1.73 m2 8 . Patients glibenclamide nicorandil , medication may interfere RIC 9 . Patients recruit another study may impact ERICCA study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Remote ischemic preconditioning</keyword>
	<keyword>Coronary artery bypass graft surgery</keyword>
	<keyword>Cardioprotection</keyword>
	<keyword>Clinical Outcomes</keyword>
</DOC>